Catalyst Pharmaceuticals, Inc.
US ˙ NASDAQCM ˙ US14888U1016 ˙ Medical Devices
DIESES SYMBOL IST NICHT MEHR AKTIV

SecurityCPRX / Catalyst Pharmaceuticals, Inc.
InstitutionRYDEX VARIABLE TRUST - Russell 2000(R) 1.5x Strategy Fund Variable Annuity
Latest Disclosed Ownership31 shares
Latest Disclosed Value $ 767
RYDEX VARIABLE TRUST - Russell 2000(R) 1.5x Strategy Fund Variable Annuity ownership in CPRX / Catalyst Pharmaceuticals, Inc.

On June 1, 2026 - RYDEX VARIABLE TRUST - Russell 2000(R) 1.5x Strategy Fund Variable Annuity filed a NPORT-P form disclosing ownership of 31 shares of Catalyst Pharmaceuticals, Inc. (US:CPRX) valued at $768 USD as of March 31, 2026. The entity filed a previous NPORT-P on March 2, 2026 disclosing 31 shares of Catalyst Pharmaceuticals, Inc.. The current value of the position is $976 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-06-01 2026-03-31 NP Catalyst Pharmaceuticals Inc. COM EC US14888U1016 31 0 0.00 1 0.0278
2026-03-02 2025-12-31 NP Catalyst Pharmaceuticals EC US14888U1016 31 0 0.00 1 0.0256
2025-12-01 2025-09-30 NP Catalyst Pharmaceuticals EC US14888U1016 31 0 0.00 1 0.0212
2025-08-27 2025-06-30 NP Catalyst Pharmaceuticals EC US14888U1016 31 1 3.33 1 0.0269
2025-05-29 2025-03-31 NP Catalyst Pharmaceuticals EC US14888U1016 30 -18 -37.50 1 -100.00 0.0293
2025-03-03 2024-12-31 NP Catalyst Pharmaceuticals EC US14888U1016 48 0 0.00 1 0.0306
2024-11-29 2024-09-30 NP Catalyst Pharmaceuticals EC US14888U1016 48 -3 -5.88 1 0.0282
2024-08-29 2024-06-30 NP Catalyst Pharmaceuticals EC US14888U1016 51 -15 -22.73 1 -100.00 0.0252
2024-05-30 2024-03-31 NP Catalyst Pharmaceuticals EC US14888U1016 66 8 13.79 1 0.0300
2024-02-29 2023-12-31 NP Catalyst Pharmaceuticals EC US14888U1016 58 0 0.00 1 0.0215
2023-11-29 2023-09-30 NP Catalyst Pharmaceuticals EC US14888U1016 58 0 0.00 1 0.0217
2023-08-28 2023-06-30 NP Catalyst Pharmaceuticals EC US14888U1016 58 0 0.00 1 -100.00 0.0214
2023-05-30 2023-03-31 NP Catalyst Pharmaceuticals EC US14888U1016 58 0 0.00 1 -100.00 0.0290
2023-02-28 2022-12-31 NP Catalyst Pharmaceuticals EC US14888U1016 58 -7 -10.77 1 0.0327
2022-11-29 2022-09-30 NP Catalyst Pharmaceuticals EC US14888U1016 65 0 0.00 1 0.0280
2022-08-29 2022-06-30 NP Catalyst Pharmaceuticals EC US14888U1016 65 -2 -2.99 0 0.0139
2022-05-26 2022-03-31 NP Catalyst Pharmaceuticals EC US14888U1016 67 1 1.52 1 0.0122
2022-02-28 2021-12-31 NP Catalyst Pharmaceuticals EC US14888U1016 66 66 0 0.0064
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.